ATGE Stock Recent News

Adtalem Global stock is hitting all-time highs in the current stock market with its focus on health care education services.

Adtalem Global Education Inc. (NYSE:ATGE ) Q3 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Jay Spitzer - VP of IR Steve Beard - Chairman and CEO Bob Phelan - CFO Conference Call Participants Jack Slevin - Jefferies Jeff Silber - BMO Capital Markets Alex Paris - Barrington Research Steve Pawlak - Baird Operator Greetings and welcome to the Adtalem Global Education Third Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Adtalem Global Education (ATGE) came out with quarterly earnings of $1.92 per share, beating the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.50 per share a year ago.

CHICAGO--(BUSINESS WIRE)--The program reflects operational excellence through Adtalem's Growth with Purpose strategy, robust cash generation and disciplined capital allocation.

Adtalem (ATGE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Adtalem (ATGE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Adtalem has beaten estimates for quarterly earnings for nearly two years running.

CHICAGO--(BUSINESS WIRE)--Adtalem and its medical schools, AUC and RUSM, today announce a combined 95% first-time residency attainment rate for 2024-2025 graduates.

The medical school's shares jumped to an all-time high on Jan. 31, when Adtalem beat analysts' expectations.

Adtalem (ATGE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.